Elicio Therapeutics, Inc. (ELTX)
2.425
-0.08
(-3.00%)
USD |
NASDAQ |
Sep 04, 16:00
2.425
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.016M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.045M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.042M |
| March 31, 2024 | 0.003M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.045M |
| June 30, 2023 | 0.03M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.017M |
| December 31, 2022 | -0.095M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.559M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.036M |
| September 30, 2021 | -0.061M |
| June 30, 2021 | -0.244M |
| March 31, 2021 | -0.041M |
| December 31, 2020 | -0.01M |
| September 30, 2020 | -0.001M |
| June 30, 2020 | -0.01M |
| March 31, 2020 | -0.02M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Precigen, Inc. | 26.69M |
| Agenus, Inc. | 0.267M |
| Amgen, Inc. | -569.00M |
| Anika Therapeutics, Inc. | -1.28M |
| BioCryst Pharmaceuticals, Inc. | -110.15M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.165M |
| Cash from Financing (Quarterly) | 16.51M |
| Free Cash Flow | -37.71M |
| Free Cash Flow Per Share (Quarterly) | -0.4243 |
| Free Cash Flow to Equity (Quarterly) | -7.973M |
| Free Cash Flow to Firm (Quarterly) | -7.755M |
| Free Cash Flow Yield | -86.45% |